Description AOD9604 (Advanced Obesity Drug 9604) is a synthetic research peptide, a fragment of human growth hormone (HGH), designed to promote fat breakdown in cells (lipolysis) and inhibit fat formation (lipogenesis) without the negative effects of full HGH, like impacting blood sugar or causing muscle / tissue growth, making it studied for weight loss and metabolic health
Each vial contains sterile water and is preserved with 0.9% benzyl alcohol to prevent bacterial growth, allowing for safe, repeated needle entry
TB-500: the mobility and repair peptide TB-500 is a synthetic fragment of thymosin beta-4, a naturally occurring 43-amino-acid peptide involved in cell migration, blood vessel formation, and tissue repair
Medical Considerations Low IGF-1 with symptoms of GH deficiency may warrant: GH stimulation testing Consideration of GH or peptide therapy under endocrinology or functional medicine guidance High IGF-1 may require: Acromegaly screening (IGF-1 + oral glucose tolerance GH suppression test) Adjustment of therapy dosages Cancer risk assessment and monitoring IGF-1, Longevity, and Health Span The relationship between IGF-1 and lifespan is U-shaped both extremes are associated with higher risk